Application | Comment | Organism |
---|---|---|
medicine | a phase II trial of enzastaurin is conducted to determine the 6-month progression-free survival rate in advanced non-small-cell lung cancer using Enzaustaurin: 13% of the patients have a progression-free survival for more than 6 months | Homo sapiens |
Inhibitors | Comment | Organism | Structure |
---|---|---|---|
enzastaurin | oral serine/threonine kinase inhibitor | Homo sapiens |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Homo sapiens | - |
- |
- |
Synonyms | Comment | Organism |
---|---|---|
p-AKT | - |
Homo sapiens |
protein kinase C | - |
Homo sapiens |